Document Type : Original Article
Authors
Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Abstract
Background: The best ovarian stimulation protocol in the case of endometrioma-related infertility is still debated. In this study, we examined the effect of two ovarian stimulation protocols on in vitro fertilization (IVF)/intra-cytoplasmic sperm injection (ICSI) outcome in patients with good ovarian reserve suffering from endometrioma.
Methods: In a retrospective study, 101 women with endometrioma and good ovarian reserve were recruited. Women received either gonadotropin-releasing hormone (GnRH) agonists (n=65) or GnRH antagonists (n=36) in an IVF or ICSI cycle. Clinical and chemical pregnancy rate, live birth rate, implantation rate, fertilization rate and fertilization proportion, as well as miscarriage rate, were evaluated in both groups.
Results: Chemical (25% vs. 28.6%), clinical (19.6% vs. 25%), and live birth rates (19.6% vs. 25%) as well as implantation rate (11.7% vs. 15%) were not significantly different between the two groups. Miscarriage rate, fertilization rate and fertilization proportion were similar in the two groups.
Conclusion: GnRH antagonist protocol with the main advantages of short duration and lower cost of treatment could be applied in infertile patients with endometrioma and good ovarian reserve.
Keywords
- Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400- 12. doi: 10.1093/humrep/det457.
- Hamdan M, Dunselman G, Li TC, Cheong Y. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis. Hum Reprod Update. 2015;21(6):809-25. doi: 10.1093/humupd/dmv035.
- Prefumo F, Rossi AC. Endometriosis, endometrioma, and ART results: current understanding and recommended practices. Best Pract Res Clin Obstet Gynaecol. 2018;51:34-40. doi: 10.1016/j.bpobgyn.2018.01.019.
- Drakopoulos P, Rosetti J, Pluchino N, Blockeel C, SantosRibeiro S, de Brucker M, et al. Does the type of GnRH analogue used, affect live birth rates in women with endometriosis undergoing IVF/ICSI treatment, according to the rAFS stage? Gynecol Endocrinol. 2018;34(10):884-9. doi: 10.1080/09513590.2018.1460346.
- Bastu E, Yasa C, Dural O, Mutlu MF, Celik C, Ugurlucan FG, et al. Comparison of ovulation induction protocols after endometrioma resection. JSLS. 2014;18(3):e2014.00128. doi: 10.4293/jsls.2014.00128.
- Rodriguez-Purata J, Coroleu B, Tur R, Carrasco B, Rodriguez I, Barri PN. Endometriosis and IVF: are agonists really better? Analysis of 1180 cycles with the propensity score matching. Gynecol Endocrinol. 2013;29(9):859-62. doi: 10.3109/09513590.2013.808327.
- Pabuccu R, Onalan G, Kaya C. GnRH agonist and antagonist protocols for stage I-II endometriosis and endometrioma in in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil Steril. 2007;88(4):832-9. doi: 10.1016/j. fertnstert.2006.12.046.
- Surrey ES, Silverberg KM, Surrey MW, Schoolcraft WB. Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril. 2002;78(4):699-704. doi: 10.1016/s0015-0282(02)03373-3.
- Sallam HN, Garcia-Velasco JA, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev. 2006;2006(1):CD004635. doi: 10.1002/14651858. CD004635.pub2.
- Georgiou EX, Melo P, Baker PE, Sallam HN, Arici A, GarciaVelasco JA, et al. Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis. Cochrane Database Syst Rev. 2019;2019(11):CD013240. doi: 10.1002/14651858. CD013240.pub2.
- Hsu AL, Khachikyan I, Stratton P. Invasive and noninvasive methods for the diagnosis of endometriosis. Clin Obstet Gynecol. 2010;53(2):413-9. doi: 10.1097/ GRF.0b013e3181db7ce8.
- Gunasheela D, Murali R, Appaneravanda LC, Gerstl B, Kumar A, Sengeetha N, et al. Age-specific distribution of serum antimullerian hormone and antral follicle count in Indian infertile women. J Hum Reprod Sci. 2021;14(4):372-9. doi: 10.4103/ jhrs.jhrs_65_21.
- Lan J, Wu Y, Wu Z, Wu Y, Yang R, Liu Y, et al. Ultra-long GnRH agonist protocol during IVF/ICSI improves pregnancy outcomes in women with adenomyosis: a retrospective cohort study. Front Endocrinol (Lausanne). 2021;12:609771. doi: 10.3389/fendo.2021.609771.
- Eftekhar M, Hoseini M, Tabibnejad N. Is there a relationship between luteinizing hormone levels and ART outcome in GnRH antagonist protocols? A retrospective cross-sectional study. Indian J Endocrinol Metab. 2021;25(6):563-8. doi: 10.4103/ijem.ijem_331_21.
- Dashti S, Aflatoonian A, Tabibnejad N. Comparison of oocyte maturation trigger using follicle stimulating hormone plus human chorionic gonadotropin versus hCG alone in assisted reproduction technology cycles. Int J Fertil Steril. 2019;13(2):102-7. doi: 10.22074/ijfs.2019.5701.
- Aflatoonian A, Mansoori-Torshizi M, Farid Mojtahedi M, Aflatoonian B, Khalili MA, Amir-Arjmand MH, et al. Fresh versus frozen embryo transfer after gonadotropinreleasing hormone agonist trigger in gonadotropin-releasing hormone antagonist cycles among high responder women: a randomized, multi-center study. Int J Reprod Biomed. 2018;16(1):9-18.
- Coccia ME, Rizzello F, Mariani G, Bulletti C, Palagiano A, Scarselli G. Impact of endometriosis on in vitro fertilization and embryo transfer cycles in young women: a stage-dependent interference. Acta Obstet Gynecol Scand. 2011;90(11):1232- 8. doi: 10.1111/j.1600-0412.2011.01247.x.
- Harb HM, Gallos ID, Chu J, Harb M, Coomarasamy A. The effect of endometriosis on in vitro fertilisation outcome: a systematic review and meta-analysis. BJOG. 2013;120(11):1308-20. doi: 10.1111/1471-0528.12366.
- Opøien HK, Fedorcsak P, Omland AK, Abyholm T, Bjercke S, Ertzeid G, et al. In vitro fertilization is a successful treatment in endometriosis-associated infertility. Fertil Steril. 2012;97(4):912-8. doi: 10.1016/j.fertnstert.2012.01.112.
- Kolanska K, Cohen J, Bendifallah S, Selleret L, Antoine JM, Chabbert-Buffet N, et al. Pregnancy outcomes after controlled ovarian hyperstimulation in women with endometriosisassociated infertility: GnRH-agonist versus GnRH-antagonist. J Gynecol Obstet Hum Reprod. 2017;46(9):681-6. doi: 10.1016/j.jogoh.2017.09.007.
- Yu Y, Wei K, Yao Q, Tian S, Liang K, Zhou L, et al. [Controlled ovarian stimulation protocols in endometriosis patients: with antagonist or agonist?]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019;48(2):165-73. doi: 10.3785/j.issn.1008- 9292.2019.04.07. [Chinese].
- Zhao F, Lan Y, Chen T, Xin Z, Liang Y, Li Y, et al. Live birth rate comparison of three controlled ovarian stimulation protocols for in vitro fertilization-embryo transfer in patients with diminished ovarian reserve after endometrioma cystectomy: a retrospective study. J Ovarian Res. 2020;13(1):23. doi: 10.1186/s13048-020-00622-x.
- Bourdon M, Raad J, Dahan Y, Marcellin L, Maignien C, Even M, et al. Endometriosis and ART: a prior history of surgery for OMA is associated with a poor ovarian response to hyperstimulation. PLoS One. 2018;13(8):e0202399. doi: 10.1371/journal.pone.0202399.
)